These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1826237)
1. Effect of insulin-induced hypoglycaemia on absorption of unmodified insulin after subcutaneous or intramuscular injection. Grønlund B; Frandsen H; Lauritzen M; Nielsen SL; Madsbad S Diabet Med; 1991 Jan; 8(1):13-7. PubMed ID: 1826237 [TBL] [Abstract][Full Text] [Related]
2. Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Vaag A; Pedersen KD; Lauritzen M; Hildebrandt P; Beck-Nielsen H Diabet Med; 1990 May; 7(4):335-42. PubMed ID: 2140087 [TBL] [Abstract][Full Text] [Related]
3. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Frid A; Ostman J; Linde B Diabetes Care; 1990 May; 13(5):473-7. PubMed ID: 2190773 [TBL] [Abstract][Full Text] [Related]
4. Insulin absorption and subcutaneous blood flow in normal subjects during insulin-induced hypoglycemia. Fernqvist-Forbes E; Linde B; Gunnarsson R J Clin Endocrinol Metab; 1988 Sep; 67(3):619-23. PubMed ID: 3045145 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects. Guerra SM; Kitabchi AE J Clin Endocrinol Metab; 1976 May; 42(5):869-74. PubMed ID: 1270578 [TBL] [Abstract][Full Text] [Related]
6. Insulin-induced hypoglycaemia and absorption of injected insulin in diabetic patients. Fernqvist-Forbes E; Gunnarsson R; Linde B Diabet Med; 1989; 6(7):621-6. PubMed ID: 2527704 [TBL] [Abstract][Full Text] [Related]
7. Effects of accidental intramuscular injection on insulin absorption in IDDM. Frid A; Gunnarsson R; Güntner P; Linde B Diabetes Care; 1988 Jan; 11(1):41-5. PubMed ID: 3276476 [TBL] [Abstract][Full Text] [Related]
8. Hypoglycaemia in childhood diabetes. II. Effect of subcutaneous or intramuscular injection of different doses of glucagon. Aman J; Wranne L Acta Paediatr Scand; 1988 Jul; 77(4):548-53. PubMed ID: 3394508 [TBL] [Abstract][Full Text] [Related]
9. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects. Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803 [TBL] [Abstract][Full Text] [Related]
10. Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Thow JC; Johnson AB; Fulcher G; Home PD Diabet Med; 1990 Aug; 7(7):600-2. PubMed ID: 2146067 [TBL] [Abstract][Full Text] [Related]
11. Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Frid A; Linde B Diabet Med; 1992 Apr; 9(3):236-9. PubMed ID: 1533580 [TBL] [Abstract][Full Text] [Related]
12. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
13. Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site. Henriksen JE; Vaag A; Hansen IR; Lauritzen M; Djurhuus MS; Beck-Nielsen H Diabet Med; 1991 Jun; 8(5):453-7. PubMed ID: 1830531 [TBL] [Abstract][Full Text] [Related]
14. Variation in absorption of NPH insulin due to intramuscular injection. Vaag A; Handberg A; Lauritzen M; Henriksen JE; Pedersen KD; Beck-Nielsen H Diabetes Care; 1990 Jan; 13(1):74-6. PubMed ID: 2404719 [TBL] [Abstract][Full Text] [Related]
15. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Mudaliar SR; Lindberg FA; Joyce M; Beerdsen P; Strange P; Lin A; Henry RR Diabetes Care; 1999 Sep; 22(9):1501-6. PubMed ID: 10480516 [TBL] [Abstract][Full Text] [Related]
16. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients. Shahshahani MN; Kitabchi J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713 [TBL] [Abstract][Full Text] [Related]
17. The variability in the action of unmodified insulin is more dependent on changes in tissue insulin sensitivity than on insulin absorption. Ziel FH; Davidson MB; Harris MD; Rosenberg CS Diabet Med; 1988 Oct; 5(7):662-6. PubMed ID: 2975551 [TBL] [Abstract][Full Text] [Related]
18. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors. Hildebrandt P Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533 [TBL] [Abstract][Full Text] [Related]
19. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects. Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064 [TBL] [Abstract][Full Text] [Related]
20. Influence of circulating epinephrine on absorption of subcutaneously injected insulin. Fernqvist E; Gunnarsson R; Linde B Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]